Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 13/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.47 |
| ▸ | CDK4 | P11802 | 3/20 | 0.45 |
| ▸ | CCND1 | P24385 | 3/20 | 0.45 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29591657 | 1.00 | SLC6A2 (0.47) | SLC6A2SLC6A4CDK4CCND1NOTUM | |
| SCHEMBL31517709 | 0.98 | SLC6A2 (0.46) | SLC6A2SLC6A4CDK4CCND1NOTUM | |
| SCHEMBL1841921 | 0.83 | SLC6A4 (0.50) | SLC6A2SLC6A4NOTUM | |
| SCHEMBL17818472 | 0.83 | SLC6A4 (0.46) | SLC6A2SLC6A4CDK4CCND1NOTUM | |
| SCHEMBL20379514 | 0.83 | SLC6A2 (0.46) | SLC6A2SLC6A4CDK4CCND1 | |
| SCHEMBL24663442 | 0.83 | SLC6A4 (0.46) | SLC6A2SLC6A4CDK4CCND1NOTUM | |
| SCHEMBL30460003 | 0.83 | SLC6A4 (0.50) | SLC6A2SLC6A4NOTUM | |
| SCHEMBL10920221 | 0.83 | SLC6A2 (0.45) | SLC6A2SLC6A4CDK4CCND1NOTUM | |
| SCHEMBL2976520 | 0.83 | SLC6A4 (0.46) | SLC6A2SLC6A4CDK4CCND1NOTUM | |
| SCHEMBL3471410 | 0.79 | SLC6A2 (0.43) | SLC6A2SLC6A4CDK4CCND1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116969967-A | Synthesis method of polysubstituted-5, 10-dihydro [1,2,3,4] tetrathio [5,6-b:7,8-b' ] diindole and derivative | 衡阳师范学院 | 2023-10-31 | — | — | CN | claimed |
| CN-113121403-B | Method for preparing tri-substituted indole compound by one-step method | 江苏科技大学 | 2022-12-30 | — | — | CN | claimed |
| CN-108218897-B | Polysubstituted selenophene indole and derivative and synthetic method thereof | 湘潭大学 | 2020-12-11 | — | — | CN | claimed |
| CN-107235990-B | Polysubstituted indoles bithiophene and derivative and its synthetic method | 湘潭大学 | 2019-01-29 | — | — | CN | claimed |
| CN-108218897-A | Polysubstituted selenophen diindyl and derivative and its synthetic method | 湘潭大学 | 2018-06-29 | — | — | CN | claimed |
| CN-107235990-A | Polysubstituted indoles bithiophene and derivative and its synthetic method | 湘潭大学 | 2017-10-10 | — | — | CN | claimed |
| CN-106995400-A | A kind of compound and its salt and its synthetic method | 湘潭大学 | 2017-08-01 | — | — | CN | claimed |
| CN-103265471-A | Method for preparing fluvastatin intermediate 3-(4-fluorophenyl)-1-isopropyl-1H-indole | Qidong dongyue pharmaceutical co ltd | 2013-08-28 | — | — | CN | claimed |
| CN-121536884-B | Liquid hydrogen storage material and hydrogen storage process | 厦门爱迪特环保科技有限公司 | 2026-04-03 | — | — | CN | disclosed |
| CN-121536884-A | Liquid hydrogen storage material and hydrogen storage process | 厦门爱迪特环保科技有限公司 | 2026-02-17 | — | — | CN | disclosed |
| EP-3350215-B1 | CYSTINE KNOT SCAFFOLD PLATFORM | HOFFMANN LA ROCHE (CH) | 2025-12-03 | — | — | EP | disclosed |
| US-20250171420-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | MONTE ROSA THERAPEUTICS AG (CH) | 2025-05-29 | — | — | US | disclosed |
| CN-114591422-B | Cystine knot support platform | 豪夫迈·罗氏有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20240317685-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR | LG CHEM, LTD. (KR) | 2024-09-26 | — | — | US | disclosed |
| US-4343493-A | LEUCO DYES; CARBON-FREE; PRESSURE SENSITIVE ELEMENTS; THERMOSENSITIVITY | STERLING DRUG INC. (US) | 1982-08-10 | — | — | US | disclosed |
| US-4322352-A | Indolyl phthalide compounds | STERLING DRUG INC. (US) | 1982-03-30 | — | — | US | disclosed |
| US-4307018-A | CHROMOGENS FOR COPYING SYSTEMS | STERLING DRUG INC. (US) | 1981-12-22 | — | — | US | disclosed |
| US-4257954-A | INDOLYL-PHENYLSULFONYL-PHENYL METHANE | STERLING DRUG INC. (US) | 1981-03-24 | — | — | US | disclosed |
| US-4251446-A | COLOR PRECURSORS | STERLING DRUG INC. (US) | 1981-02-17 | — | — | US | disclosed |
| US-4189171-A | PRESSURE SENSITIVE, THERMAL AND HECTOGRAPHIC SYSTEMS | STERLING DRUG INC. (US) | 1980-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250171420-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | PSMA1, CSNK1G1, CSNK1A1 | SLC6A2 4837/4885SLC6A4 4844/4885CDK4 246/4885 |
| US-20240317685-A1 | METHOD FOR PREPARING INTERMEDIATE FOR SYNTHESIS OF XANTHINE OXIDASE INHIBITOR | XDH, PNPO, AOX1 | SLC6A2 833/4885SLC6A4 1636/4885CDK4 1777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.